Rigel Pharma (RIGL) Reports In-Line Q4 EPS, Revenues Beat
Go back to Rigel Pharma (RIGL) Reports In-Line Q4 EPS, Revenues Beat| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 1.10 -0.03 (2.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.13 | 52 Week High | $4.38 | |||
| Open | $1.12 | 52 Week Low | $1.88 | |||
| Day High | $1.14 | P/E | N/A | |||
| Day Low | $1.06 | EPS | $-1.12 | |||
| Volume | 2,971,722 | |||||
